Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2024-11-14 6:57 pm Purchase | 13G | ALIGOS THERAPEUTICS INC NE ALGS | Vivo Capital Fund VIII L.P. | 141,879 4.000% | 141,879 (New Position) | View |
2024-11-14 6:19 pm Purchase | 13G | ALIGOS THERAPEUTICS INC NE ALGS | EcoR1 Capital LLC | 356,117 9.990% | 356,117 (New Position) | View |
2024-11-14 5:03 pm Purchase | 13G | ALIGOS THERAPEUTICS INC NE ALGS | ARMISTICE CAPITAL LLC | 319,756 9.990% | 319,756 (New Position) | View |
2024-11-14 4:37 pm Sale | 13G | ALIGOS THERAPEUTICS INC NE ALGS | Alyeska Investment Group L.P. | 146,472 4.800% | -7,030,295 (-97.96%) | View |
2024-11-14 4:34 pm Purchase | 13G | ALIGOS THERAPEUTICS INC NE ALGS | HHLR ADVISORS LTD. | 125,069 4.000% | 125,069 (New Position) | View |
2024-11-12 09:31 am Purchase | 13G | ALIGOS THERAPEUTICS INC NE ALGS | Adage Capital Management L.P. | 218,813 7.120% | 218,813 (New Position) | View |
2024-09-12 4:21 pm Purchase | 13G | ALIGOS THERAPEUTICS INC NE ALGS | ICS OPPORTUNITIES II LLC | 125,451 4.100% | 125,451 (New Position) | View |
2024-02-14 5:07 pm Purchase | 13G | ALIGOS THERAPEUTICS INC NE ALGS | EcoR1 Capital LLC | 7,264,147 9.990% | 3,315,787 (+83.98%) | View |
2024-02-14 4:37 pm Purchase | 13G | ALIGOS THERAPEUTICS INC NE ALGS | HHLR ADVISORS LTD. | 5,971,426 8.200% | 3,661,662 (+158.53%) | View |
2024-02-14 4:21 pm Purchase | 13G | ALIGOS THERAPEUTICS INC NE ALGS | BAKER BROS. ADVISORS LP | 3,664,013 4.990% | 1,587,613 (+76.46%) | View |
2024-02-14 4:00 pm Sale | 13G | ALIGOS THERAPEUTICS INC NE ALGS | TANG CAPITAL PARTNERS LP | 2,189,847 3.000% | -626,544 (-22.25%) | View |
2024-02-14 3:23 pm Purchase | 13G | ALIGOS THERAPEUTICS INC NE ALGS | ARMISTICE CAPITAL LLC | 7,214,823 9.990% | 7,214,823 (New Position) | View |
2024-02-14 1:53 pm Purchase | 13G | ALIGOS THERAPEUTICS INC NE ALGS | Alyeska Investment Group L.P. | 7,176,767 9.990% | 7,176,767 (New Position) | View |
2024-02-08 5:44 pm Unchanged | 13D | ALIGOS THERAPEUTICS INC NE ALGS | Versant Venture Capital VI L.P. | 1,457,937 1.900% | 0 (Unchanged) | View |
2023-11-07 5:16 pm Purchase | 13G | ALIGOS THERAPEUTICS INC NE ALGS | ROCHE FINANCE LTD | 11,025,941 15.350% | 7,933,601 (+256.56%) | View |
2023-11-06 4:05 pm Purchase | 13D | ALIGOS THERAPEUTICS INC NE ALGS | BLATT LAWRENCE | 3,888,253 5.300% | 1,210,283 (+45.19%) | View |
2023-11-02 4:08 pm Purchase | 13G | ALIGOS THERAPEUTICS INC NE ALGS | Deep Track Capital LP | 7,295,967 9.990% | 7,295,967 (New Position) | View |
2023-02-14 4:10 pm Sale | 13G | ALIGOS THERAPEUTICS INC NE ALGS | HHLR ADVISORS LTD. | 2,309,764 5.800% | -55,300 (-2.34%) | View |
2023-02-14 4:00 pm Purchase | 13G | ALIGOS THERAPEUTICS INC NE ALGS | TANG CAPITAL PARTNERS LP | 2,816,391 7.100% | 457,491 (+19.39%) | View |
2023-02-13 08:25 am Purchase | 13G | ALIGOS THERAPEUTICS INC NE ALGS | EcoR1 Capital LLC | 3,948,360 9.900% | 735,060 (+22.88%) | View |